Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B

Published:2016-09-15 Issue:9 Volume:44 Page:957-966
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Marcellin P.¹,Ahn S. H.²,Chuang W.-L.³,Hui A. J.⁴,Tabak F.⁵,Mehta R.⁶,Petersen J.⁷,Lee C.-M.³,Ma X.⁸,Caruntu F. A.⁹,Tak W. Y.¹⁰,Elkhashab M.¹¹,Lin L.¹²,Wu G.¹²,Martins E. B¹²,Charuworn P.¹²,Yee L. J.¹²,Lim S. G.¹³,Foster G. R.¹⁴,Fung S.¹¹,Morano L.¹⁵,Samuel D.¹⁶,Agarwal K.¹⁴,Idilman R.¹⁷,Strasser S. I.¹⁸,Buti M.¹⁹,Gaeta G. B.²⁰,Papatheodoridis G.²¹,Flisiak R.²²,Chan H. L. Y.⁴

Affiliation:

1. Paris France

2. Seoul South Korea

3. Kaohsiung Taiwan

4. Hong Kong China

5. Istanbul Turkey

6. Surat India

7. Hamburg Germany

8. Philadelphia USA

9. Bucharest Romania

10. Daegu South Korea

11. Toronto ON Canada

12. Gilead Sciences, Inc., Foster City CA USA

13. Singapore

14. London UK

15. Pontevedra Spain

16. Villejuif France

17. Ankara Turkey

18. Sydney Australia

19. Barcelona Spain

20. Naples Italy

21. Athens Greece

22. Bialystok Poland

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13779/fullpdf

Reference26 articles.

1. EASL Clinical Practice Guidelines: management of hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2012

2. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update;Liaw;Hepatol Int,2012

3. AASLD guidelines for treatment of hepatitis B;Terrault;Hepatology,2015

4. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;Marcellin;N Engl J Med,2004

5. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;Lau;N Engl J Med,2005

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B cure: Current situation and prospects;World Journal of Hepatology;2024-06-27

2. Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients;Clinical and Molecular Hepatology;2024-04-01

3. Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen;PLOS ONE;2023-11-01

4. Combination treatment of pegylated interferon and tenofovir versus tenofovir for people with chronic hepatitis B;Cochrane Database of Systematic Reviews;2023-08-04

5. Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients;Infection and Drug Resistance;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3